IL6 and depressive disorder: Activation of GPR55 using O-1602 inhibited the activation of the inflammasome, normalizing the increased expression of IL-1β (IL-6 and TNF) and the decreased expression of IL-4 and IL-10, respectively reducing the depression- and anxiety-like behavior [70].